Healy John Stephen has filed 3 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 206411 shares of Contineum Therapeutics, Inc. ($CTNM) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Contineum Therapeutics, Inc. | $CTNM | Healy John Stephen | General Counsel and Corp Sec | A | Stock Option (right to buy) | 206411 | $0.00 | 206,411.0000 | 28,115,548 | 9999.99% | 0.73% |
| Jan. 31, 2025 | Contineum Therapeutics, Inc. | $CTNM | Healy John Stephen | General Counsel and Corp Sec | A | Stock Option (right to buy) | 63589 | $0.00 | 63,589.0000 | 19,352,859 | 9999.99% | 0.33% |
| June 3, 2024 | Contineum Therapeutics, Inc. | $CTNM | Healy John Stephen | General Counsel and Corp Sec | A | Stock Option (right to buy) | 160000 | $0.00 | 160,000.0000 | 2,308,972 | 9999.99% | 6.93% |